Up to Now, We have confirmed more than 200 company and institute, Organization to participate our 3rd China Vaccine Focus in Beijing.

Series Speaker Faculty

Shen Xinliang
Chief scientific Officer
China National Biotech Group
Dong XiaoPing
Director
The Chinese Center
for Disease Control
and Prevention (CCDC)
Qiu Hongwei
Director Policy Planning
China National Center
for Biotechnology
Development
JIN Yulan
President
Shanghai Institute of
Biological Products

Zhang Aihua
Director R&D Department
China National Biotech Group

Michael O’Leary
Chief Rep
WHO
Jean-Denis SHU
Medical Director
Sanofi Pasteur
Biological Products
Co. Ltd.
Wang Youchun
Vice Director
China National Institute for Food and Drug Control
Dr. Nicholas JACKSON
Senior Director, Vaccine Research
Pfizer
Wang Huaqing
Deputy Director, Immune Plan Center
Chinese Center for Disease Control and Prevention
Xiang Liao
Managing Director
Confluence Bio Ventures, LLC
STEVE ILIC
Senior Director
CSL Bioerathepy
B.G.RHEE
President
Green Cross
Yang Guang
Director, Investor Relations & International Business Development
Sinovac Biotech
Gong Yanhua
General Secretary
CROU
Yanee HUTAGALUNG
Regional Director Clinical Development
Sanofi Pasteur

Tim Hirst
Executive chairman
Gamma Vaccine

Wang Yu
General Director
China Disease prevention and Control Center
Yu Xuefeng
Chairman and General Manager
Tianjing Cansino Biotechnology Inc
Li Yunchun
Chairman
Walvax Biotechnology Co., Ltd
Wu Changyou
Director of Immunization Department
ZhongShan School of Medicine
Zhang Yi
General Manager
Jiangsu Walvax Biotech Inc
       

Delegates

Company participants
  • BIA Separations Co. Ltd.,
    Austria
  • Biomay AG, USA
  • Biomedical Research Models,
    Inc, USA
  • Brenntag Biosector A/S,
    Denmark
  • Caerus Discovery, LLC, USA
  • Charles River Laboratories
    International Inc, USA
  • Chilka Limited, Switzerland
  • Clinique des Grangettes, Switzerland
  • Crucell Switzerland AG,
    Switzerland China National
    Biotec Group Co.Ltd.
    (CNBG), China
  • Dormer-Owusu BioInstitute,
    Inc., USA
  • EMD Millipore Corporation,
    USA
  • Glaxo-SmithKline Biologicals, Belgium
  • Global Bio RD at Ceva Animal Health, USA
  • HiSS Diagnostics GmbH,
    Germany
  • ImmunoVaccine Technologies
    Inc., Canada
  • Impfstoffwerk Dessau- Tornau GmbH, Germany
  • Lentigen Corporation, USA
  • Light Sciences Oncology, Inc., USA
  • MedImmune LLC, USA
  • Merck Animal Health, USA
  • Merck Research Lab, USA
  • Mucosis BV, Groningen, The Netherlands
  • NNE Pharmaplan, Denmark
  • Novartis Vaccine& Diagnostics, Italy
  • Novartis Vaccines Institute for Global
    Health, Italy
  • Novartis Vaccines, USA
  • Novavax, Inc., USA
  • Pfizer Pharmaceuticals, Italy
  • Philimmune LLC, USA
  • Sanofi Pasteur Biologics Co., USA
  • Sanofi Pasteur, China
  • Sanofi Pasteur, Singapore
  • Scancell Ltd, UK
  • Strategic Manufacturing Worldwide, Inc, USA
  • Vaccinogen, Inc., USA
  • Impfstoffwerk Dessau- Tornau GmbH, Germany
  • Lentigen Corporation, USA
  • Light Sciences Oncology, Inc., USA
  • MedImmune LLC, USA
  • Merck Animal Health, USA
  • Merck Research Lab, USA
  • Mucosis BV, Groningen, The Netherlands
  • NNE Pharmaplan, Denmark
  • Novartis Vaccine& Diagnostics, Italy
  • Novartis Vaccines Institute for Global
    Health, Italy
  • Afro-European Medical and Research Network, Switzerland
  • Aglaia BioMedical Ventures,
    The Netherlands
  • Alphalyse A/S, Denmark
  • Antagen Biosciences, Inc., USA
  • Antagen Institute for
    Biomedical Research, USA
  • Arbovax, Inc., USA
  • Asia Pacific & China, BIA
    Separations Co. Ltd., Austria
  • Asia PacificTechnical &
    Marketing Manager, SEPPIC, China
  • BIA Separations Co. Ltd., Austria
  • Biomay AG, USA
  • Biomedical Research Models,
    Inc, USA
  • Brenntag Biosector A/S, Denmark
  • Caerus Discovery, LLC, USA
  • Charles River Laboratories
    International Inc, USA
  • Chilka Limited, Switzerland
  • Clinique des Grangettes, Switzerland
  • Crucell Switzerland AG,
    Switzerland China National
    Biotec Group Co.Ltd.
    (CNBG), China
  • Dormer-Owusu BioInstitute, Inc., USA
  • EMD Millipore Corporation,
    USA
  • Glaxo-SmithKline Biologicals, Belgium
  • Global Bio RD at Ceva Animal Health, USA
  • HiSS Diagnostics GmbH, Germany
  • ImmunoVaccine Technologies
    Inc., Canada
  • Impfstoffwerk Dessau- Tornau GmbH, Germany Lentigen Corporation, USA
  • Light Sciences Oncology, Inc., USA
  • MedImmune LLC, USA
  • Merck Animal Health, USA
  • Merck Research Lab, USA
  • Mucosis BV, Groningen, The Netherlands
  • NNE Pharmaplan, Denmark
  • Novartis Vaccine & Diagnostics, Italy
  • Novartis Vaccines Institute for Global
    Health, Italy
  • Novartis Vaccines, USA
  • Novavax, Inc., USA
  • Pfizer Pharmaceuticals, Italy
  • Philimmune LLC, USA
  • Sanofi Pasteur Biologics Co., USA
  • Sanofi Pasteur, China
  • Sanofi Pasteur, Singapore
  • Scancell Ltd, UK
  • Strategic Manufacturing Worldwide, Inc, USA
  • Vaccinogen, Inc., USA
Academic Institute
  • Libre de Bruxelles, Belgium.
  • Children’s Hospital of Eastern
    Ontario, Canada
  • Chinese Academy of Agricultural
    Sciences, China
  • Harvard Medical School, USA
  • James H Quillen VA Medical
    Center, East Tennessee State
    University, USA
  • Jazan University, Saudi Arabia
  • Kyushu University, Japan
  • Long Island Jewish Medical Center, USA
  • Medical University of Vienna, Austria
  • Murdoch University, Australia
  • National Institutes of Health, USA
  • Nuclear Research Center of
    Kinshasa, Democratic Republic
    of the Congo
  • O.I.E., FAO and National
    Reference Laboratory, Germany
  • Protein Interactions Group, CCRNP, CCR, NCI-Frederick, USA
  • Qingdao Agricultural University, China
  • Shandong University, China
  • The David H. Koch Institute for Integrative Cancer Research, USA
  • The University of California at San Francisco, USA
  • The Weizmann Institute of Science, Israel
  • Universite Libre de Bruxelles, Belgium
  • University Medical Center
    Hamburg-Eppendorf, Germany
  • University of Connecticut Health

 

  • Center, USA
  • University of Copenhagen, Denmark
  • University of Georgia, USA
  • University of Hawaii, USA
  • University of Louisville, USA
  • University of Pittsburgh Graduate School of Public Health and School of Medicine, USA
  • University of Pretoria, South Africa 
  • University of Sao Paulo, Brazil
  • US Army Medical Corps, USA
  • VIDO/InterVac, Canada
  • World Health Organization, Belgium
  • World Health Organization, Morocco
  • Yeshiva University ,USA
  • Zhejiang Academy of Medical
    Sciences, China
  • PATH, USA
  • NIAID, USA
  • Ben-Gurion University of the Negev, Israel
  • Center of Structural Biology
    and Bioinformatics, Université
    Libre de Bruxelles, Belgium.
  • Children’s Hospital of Eastern
    Ontario, Canada
  • Chinese Academy of Agricultural
    Sciences, China
  • Harvard Medical School, USA
  • James H Quillen VA Medical
    Center, East Tennessee State
    University, USA
  • Jazan University, Saudi Arabia
  • Kyushu University, Japan
  • Long Island Jewish Medical Center, USA
  • Medical University of Vienna, Austria
  • Murdoch University, Australia
  • National Institutes of Health, USA
  • Nuclear Research Center of Kinshasa, Democratic Republic of the Congo
  • O.I.E., FAO and National Reference Laboratory, Germany
  • Protein Interactions Group, CCRNP, CCR, NCI-Frederick, USA
  • Qingdao Agricultural University, China
  • Shandong University, China
  • The David H. Koch Institute for Integrative Cancer Research, USA
  • The University of California at
    San Francisco, USA
  • The Weizmann Institute of Science, Israel
  • Universite Libre de Bruxelles, Belgium
  • University Medical Center Hamburg-Eppendorf, Germany
  • University of Connecticut Health Center, USA
  • University of Copenhagen, Denmark
  • University of Georgia, USA
  • University of Hawaii, USA
  • University of Louisville, USA
  • University of Pittsburgh Graduate School of Public Health and School of Medicine, USA
  • University of Pretoria,
  • South Africa 
  • University of Sao Paulo, Brazil
  • US Army Medical Corps, USA
  • VIDO/InterVac, Canada
  • World Health Organization, Belgium
  • World Health Organization, Morocco
  • Yeshiva University ,USA
  • Zhejiang Academy of Medical Sciences, China
*There are only 2 exhibition and 15 participants opportunity left, please not miss the unprecedented opportunity to interact and greet more than 200 Vaccine Industry Elites and 30 distinguished speakers to discuss the developing trend of Vaccine!

There are Six principal Features of our 3rd China Vaccine Focus :

1, More than 300 Worldwide Vaccine Maker's Top Leaders Gather Here to Enjoy the Sophisticated Vaccine Technology and Enthusiastic Vaccine-Theme Brain storm 2, Fascinating Topics and Panel Discussion Derive from All Hot Parts of Vaccine Industry Developing Trend. Key People from Major Positions of China Vaccine Industry and Government Pharmacy Department.
3, Pay Tremendous Attention to New Flu Vaccine R&D
  • 4, Cover New National Immunization Strategy for Better Polio Vaccine Using . Chinese Pharmacopoeia Commission unveil new pharmacy standard
5, Heavily Focus on the Vaccine Industry's Sustainable Development Model 6, Established by CDMC, China ABO, China Biotech pharmacy Association Together.More Than 40 Well-Known World Media Coverage

Please Listen to Our Distinguished Participants

Very Excellent conference, The Participants are all very high level and distinguished, I would continue to pay huge attention to it!
---------Shen Xinliang, Chief Scientific Officer,China National Bio-Tech Group

Very good experience at the event. The networking is very good. I got contacts of people my company may do business with
--------- li YunChun, Chairman, Walvax Biotechnology Co., Ltd.

“A quality networking platform! It worked out really well for my company and the organization was as good as always”
--------Wang Yu, General Director, China Disease Control and Prevention Center
Very Nice Summit , a good place to benefit the greatness from booming China Vaccine Industry
---------Yu Xuefeng,General Manager,Tianjing Cansino Biotechnology Inc

 A very Nice place to speak to all the suppliers, operators and business partners
----------Tim Hirst, Executive Chairman, Gamma Vaccine

There are no better place for me to meet and greet Vaccine experts , business partner, top leaders then in China Vaccine Focus --------- Jean-Denis SHU, Medical Director,Sanofi Pasteur

China Vaccine Focus give me great chance to know the latest development of Vaccine R&D and Manufacturing
--------Jin Yulan, General Manager, Shanghai Institute of Biological Products

A very good chance to know the new Vaccine Immunization Strategy and policy
-------Wang Huaqing,Director of Immune Plan Center,Chinese Center for Disease Control and Prevention

China Vaccine Focus truly help the improvement the progress of Vaccine Industry consolidation. I would continue pay attention to it.
-------Wang Youchun, Deputy Director,China National Institute for Food and Drug control
China Vaccine Focus pay huge attention to the new policy, industry development , vaccine safety issue, it is also great chance for us to meet each other of Vaccine Field!
------- Michael O’Leary,Chief Rep,World Healthy Organization
Very Excellent and professional summit,I benefit from it so much,I hope the series would be consecutively successful!
-------Zheng haifa,General Manager,Beijing Minhai Biotechnology Co., Ltd
The organize of this conference is great, I would participate the next one!
-------Dong Xiaoping, Deputy Director of Viral ,China Disease control and Prevention Center
Very Well Designed, Very Impressed with Choices of Speakers, Very Impressive Conference with Very Interesting Insights!
------- Nicholas JACKSON, Senior Director,Pfizer Vaccine Research
Very Nice Conference, I gain many constructive relationship with my Chinese Colleague during the conference, It help me so much for me to take part in the China Market!
---------B.G. RHEE,Chairman,Korea Green Cross
As a Part of China Vaccine Industry, I hope to participate more Vaccine Conference like this!
----------Liao Xiang,Managing Director,Confluence Bio Ventures , LLC
Very Well Designed Conference with good Contents, it is very professional and impressive , I would participate next time
----------Yanee HUTAGALUNG,Regional Director Clinical Development,Sanofi Pasteur

Thanks to series sponsors

说明: 百得实验室仪器(中国)有限公司.tif
赛多利斯斯泰迪生物技术
(北京)有限公司
说明: 颇尔 logo.gif
颇尔过滤器(北京)有限公司

金唯智生物科技有限公司

北京桑翌实验仪器研究所

上海依科赛生物制品有限公司

杭州中肽生化有限公司

艾贝泰制药设备科技有限公司

Randox Life Sciences

武汉优尔生科技股份有限公司

百会逹有限公司

无锡加莱克色谱科技有限公司

上海复日科技有限公司

京天成生物技术(北京)有限公司

北京希凯创新科技有限公司

吴江近岸蛋白质科技有限公司

奥星集团

广州兹尼生物科技有限公司

上海比奥实业发展有限公司

默克 密理博

武汉禾元生物科技有限公司

艾森生物(杭州)有限公司

莎斯特(上海)贸易有限公司

北京康碧泉生物科技有限公司

QUANTUM量子科学仪器
贸易(北京)有限公司

北京义翘神州生物技术有限公司

苏州杰恩生物技术有限公司


仕必纯贸易(上海)有限公司

北京傲锐东源生物科技有限公司

    

 

Advisory and Judging:


Institute of medical biology Chinese academy of medical science

State food and drug administration

China national biotech group

China medicinal biotech association

Key issues to be discussed include:

    • The best approach to leading technology innovation in the Vaccine industry
    • Broaden the outlook of fast growing Vaccine product demand in China
    • China’s growing middle class and its increasing demanding for Vaccine
    • The new opportunity and challenge for Bio pharmacy industry after the global financial crisis
    • The emerging market bring tremendous impetus for strong growth of Vaccine industry
    • The emerging spreading infectious disease around world bring incredible opportunity to Vaccine market growth
    • Vaccine’s unique advantage and competitive edge for business outlook over other conventional pharmacy category
    • Vaccine business cooperation in the global context
Want to hear these topics? Register now!
Share your view on these issues

Why should you Attend In 2013?

  • Understanding the latest government policy to successfully adjust your business strategy.
  • Seize the unique opportunity to network with the leading executives and expert in the Vaccine industry
  • Participate in workshops on the latest strategies, share best practices with your market peers
  • Accessing to the latest technology and innovation in Vaccine industry.
  • Enjoying most stimulating light shed from Chinese booming Vaccine industry and expert’s ideas
  • Joining the most high level Vaccine workshop and panel discussion to further gain exclusive insight of this industry and expert.
  • Approaching the most dominant players in this industry by exclusive one-one meeting
  • Establish partnerships with the most important solution providers doing – or planning to do – business in the region
  • Gaining global competitiveness by building the exclusive global network during this event.
 

Don't just take our word for it:

  • R“Great job bringing suppliers and buyers together at the same conference. Good inch for ongoing efforts next year.
    —— LG Life Sciences
  • Very good experience at the event. The networking is very good. I got contacts of people my company may do business with.”
    —— Emball'iso Cold Chain Technology
  • “A high-quality platform! It worked out really well for my company to showcase the latest technologies and solution to our clients and the organizer was as good as always.”
    —— Colder Products Company

Who You Will Meet:

By Sector By title


 

 

  Series Media: